蛋白氨酸酸酶4A1 (PTP4A1) 调节结肠直肠癌早期事件 在老年男性宿主中腹腔内传播
Zhikun Wang1,2, Yueying Liu1,2, Jing Yang1,2
1Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, Indiana, US.
概括
老年雄性小鼠的结直肠癌 (CRC) 转移率最高. 蛋白氨酸酸酶4A1 (PTP4A1) 在老年男性中表达高,并促进转移,这表明它是CRC的治疗点.
科学领域:
- 在瘤学瘤学.
- 老年学是指老年学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 年龄和生物性别是癌症发病率和转移的重要风险因素.
- 结肠直肠癌 (CRC) 的发病率和转移死亡率在男性中比女性更高.
- 了解转移的性别和年龄差异对于向治疗至关重要.
研究的目的:
- 为了比较结肠直肠癌 (CRC) 转移负担,年轻人与老年雌性和雄性小鼠使用同基因小鼠腹腔内膜 (i.p.) 转移模型.转移模型.
- 为了识别与CRC转移的性别和年龄差异相关的腹介质细胞中差异表达的蛋白质.
- 调查已识别的蛋白质在癌症 - 中皮细胞相互作用中的作用,并探索潜在的治疗点.
主要方法:
- 使用了一种同源性小鼠腹腔内膜 (I.P.) 转移模型与MC-38结直肠癌 (CRC) 细胞.
- 量化瘤负担在年轻和老年雌雄小鼠的纵向和终点.
- 在初级小鼠腹膜间皮质细胞上进行了自下而上的蛋白质组分析,以确定差异表达的蛋白质.
主要成果:
- 年龄较大的雄性小鼠表现出最高的IP值. 转移性负担,回顾人类流行病学数据.
- 蛋白质组学分析发现,与其他队列相比,老年雄性小鼠中的蛋白氨酸酸酶4A1 (PTP4A1) 过度表达.
- 发现PTP4A1促进了癌细胞与甲状腺细胞的粘附,其抑制剂 (CMPD-43) 降低了RhoA活性和异型细胞的粘附.
结论:
- 这项研究提供了一个比较性蛋白质学资源,用于跨性别和基于年龄的队列的腹膜间皮细胞.
- 功能数据表明PTP4A1促进CRC转移,特别是在老年男性中.
- 在特定患者群体中,PTP4A1代表了阻止结直肠癌 (CRC) 转移的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K


